IRhythm Technologies Is Maintained at Outperform by Oppenheimer

Dow JonesJan 8 22:10 · Ratings

Oppenheimer Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $120

Futu NewsJan 8 21:34 · Ratings

Express News | IRhythm Technologies Inc : Oppenheimer Raises Target Price to $120 From $105

BreakingsJan 8 21:18

The Zacks Analyst Blog Highlights Tempus AI, IRhythm Technologies and SOPHiA GENETICS

Zacks Jan 8 21:05

Oppenheimer Sticks to Their Buy Rating for Irhythm Technologies (IRTC)

TipRanksJan 8 20:36 · Ratings

Wearable Patch Market Report 2025, With Profiles of Key Players Abbott, Medtronic, Dexcom, GlucoWatch, IRhythm Technologies, Insulet, Tactile Medical, VitalConnect, Qardio Myant & BioTelemetry

Yahoo FinanceJan 6 19:45